login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
MINERVA NEUROSCIENCES INC (NERV) Stock News
USA
- NASDAQ:NERV -
US6033802058
-
Common Stock
4.2
USD
+0.16 (+3.96%)
Last: 10/31/2025, 8:03:19 PM
4.14
USD
-0.06 (-1.43%)
After Hours:
10/31/2025, 8:03:19 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NERV Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Chartmill
- Mentions:
MSN
PRPH
IBIO
ARCT
...
Top movers in Wednesday's session
11 days ago - By: Chartmill
- Mentions:
MSN
WGO
VICR
PRPH
...
There are notable gap-ups and gap-downs in today's session.
5 days ago - By: Benzinga
- Mentions:
PRE
KIDS
AVR
AKBA
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
11 days ago - By: Benzinga
- Mentions:
SLP
IBIO
PRPH
ARCT
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 days ago - By: Stocktwits
Minerva Neurosciences Stock Hits Near 2-Year High On FDA Pathway, $200M Boost — Retail Sees FDA Catalyst
12 days ago - By: Chartmill
- Mentions:
F
NVDA
ADAP
BYND
...
These stocks are the most active in today's session
12 days ago - By: Chartmill
- Mentions:
GSIT
IBIO
ADAP
GLPG
...
These stocks that are showing activity before the opening bell on Tuesday.
12 days ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation
12 days ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation
3 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results
3 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results
6 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
6 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
8 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
8 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
a year ago - By: InvestorPlace
NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024
a year ago - By: BusinessInsider
NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
2 years ago - By: InvestorPlace
NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024
2 years ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
2 years ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
2 years ago - By: Seeking Alpha
Minerva stock falls as FDA rejects schizophrenia drug
Please enable JavaScript to continue using this application.